Patents for A61P 17 - Drugs for dermatological disorders (106,455)
07/2003
07/31/2003CA2474623A1 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof
07/31/2003CA2473927A1 Methods and compositions for treating polycystic ovary syndrome
07/31/2003CA2473916A1 Radiation protector and utilization thereof
07/31/2003CA2473841A1 Film-forming compositions and methods
07/31/2003CA2473796A1 Substituted quinazolin-4-ylamine analogues
07/31/2003CA2473781A1 Glycoisoforms of adiponectin and uses thereof
07/31/2003CA2473740A1 Methods of treating conditions associated with an edg receptor
07/31/2003CA2473545A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
07/31/2003CA2473490A1 Peptide-carrying bodies for immune response
07/31/2003CA2473474A1 Alteration of rab38 function to modulate mammalian pigmentation
07/31/2003CA2473395A1 Phospholipid bodies and use thereof in medical treatment
07/31/2003CA2472682A1 Treating stress response with chemokine receptor ccr5 modulators
07/31/2003CA2472367A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
07/31/2003CA2472239A1 3-(imidazolyl)-2-aminopropanoic acids for use as tafi-a inhibitors for the treatment of thrombotic diseases
07/31/2003CA2472238A1 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors
07/31/2003CA2471740A1 Pharmaceutically acceptable phosphate-glycerol carrying bodies
07/31/2003CA2471342A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
07/30/2003EP1331007A2 Chinese herbs extract
07/30/2003EP1330999A1 Melanogenesis inhibitors and whitening agents comprising ergosterol derivative and compositions containing ergosterol derivative
07/30/2003EP1330548A2 Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries
07/30/2003EP1330535A2 Kini-3 motor protein and methods for its use
07/30/2003EP1330455A1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same
07/30/2003EP1330453A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents
07/30/2003EP1330452A2 Pyrazine derivatives as modulators of tyrosine kinases
07/30/2003EP1330448A2 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders
07/30/2003EP1330439A1 (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine
07/30/2003EP1330436A1 N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr3-3 receptor antagonists
07/30/2003EP1330430A2 Integrin receptor inhibitors
07/30/2003EP1330268A1 Targeted therapeutic agents
07/30/2003EP1330235A2 Method and dermatological and/or cosmetic composition for inhibiting the adhesion effect of circulating cells
07/30/2003EP1330233A1 Method of treating stroke
07/30/2003EP1330221A2 Medical compositions, dressings and methods for treating microbial infections of skin lesions
07/30/2003EP1330166A1 Food grade transglutaminase inhibitor and uses thereof
07/30/2003EP1330164A1 Antibacterial agents, and antibacterial and deodorizing solution comprising the same
07/30/2003EP1187817B1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
07/30/2003EP1181288B1 Bicyclic oxazolidinones as antibacterial agent
07/30/2003EP1180035A4 NON-CALCEMIC, ANTIPROLIFERATIVE, TRANSCRIPTIONALLY ACTIVE SULFUR-CONTAINING ANALOGS OF 1$g(a), 25-DIHYDROXY VITAMIN D 3?
07/30/2003EP1075256B1 Arylhydrocarbon receptor ligand antagonists
07/30/2003EP0981355B1 Treatment of chronic inflammatory diseases with cm101/gbs toxin
07/30/2003EP0946541B1 Quinolines and their therapeutic use
07/30/2003CN2562768Y Anti-infection wound adhesive plaster
07/30/2003CN1433429A Oligopeptides
07/30/2003CN1433416A N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamideinhibitors of cyclin dependent kinases
07/30/2003CN1433415A N-[5-[[[5-alkyl-2-oxazlyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases
07/30/2003CN1433412A Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
07/30/2003CN1433411A Chemical compounds
07/30/2003CN1433408A Aminothiazole inhibitors of cyslin dependent kinases
07/30/2003CN1433405A Quinazoline compounds
07/30/2003CN1433382A Particle comprising host lattice and guest, its preparation and use in ultravioletlight screening compositions
07/30/2003CN1433316A Biologically active agents and drugs
07/30/2003CN1433297A Topical compositions comprising protected functional thiols
07/30/2003CN1432410A External prepn for stopping skin pain quickly
07/30/2003CN1432403A Carbuncle and deep-rooted ulcer treating glossy ganoderma wine
07/30/2003CN1432389A Xuerongguyugao ointment for healing fracture and its prepn
07/30/2003CN1432378A Medicine for treating burns and scalds and its prepn process
07/30/2003CN1432376A Scar treating Chinese medicine composition
07/30/2003CN1432372A Natural medicine for resisting electromagnetic radiation and tumor
07/30/2003CN1432357A Fever allaying prepn containing xylitol
07/30/2003CN1116304C Organic compound
07/30/2003CN1116283C Cyanoguanidines as well proliferation inhibitors
07/30/2003CN1116270C Novel retinoids derivs.
07/30/2003CN1116068C Medicine for treating ichthyosis and preparing process thereof
07/30/2003CN1116058C Chinese-medicinal plaster for treating spontaneousor night sweating and its preparing process
07/30/2003CN1116051C Pref. of black ointment for curing furuncle, pain, swelling and skin ulcer
07/30/2003CN1116048C External-use extract for treating burns and scalds fast and its preparation
07/30/2003CN1116038C External medicine for treating acne
07/30/2003CN1116032C Tincture for curing skin diseases
07/30/2003CN1116022C Shampoo
07/30/2003CN1115965C Natural plant disinfectant and its preparation
07/29/2003US6600059 Protecting cells from injury due to intrinsic membrane lysis, oxidation and/or invasion by destructive agents. Even more particularly, the present invention provides compositions and methods for treating or prophylactically inhibiting
07/29/2003US6600058 Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments
07/29/2003US6600038 Carbamoyl tetrahydropyridine derivatives
07/29/2003US6600037 4,5-disubstituted-2-aminopyrimidines
07/29/2003US6599938 Optionally substituted Schiff base condensation products comprising an amino acid component and a benzaldehyde component, that have MIF (macrophage migration inhibitory factor) antagonist activity
07/29/2003US6599934 3,4-diaryl thiopenes and analogs thereof having use as antiinflammatory agents
07/29/2003US6599932 Highly selective in killing tumor cells but not normal cells
07/29/2003US6599925 Cardiovascular disorders; anticancer agents
07/29/2003US6599912 Methods and compositions for modulating cell proliferation and cell death
07/29/2003US6599910 Substituted triazole compounds
07/29/2003US6599890 Inhibitors of matrix metalloproteinases or the production of tumor necrosis factor
07/29/2003US6599888 These combinations have shown a synergistic effect compared with compositions containing either glucosamine alone, or chondroitin sulfate alone
07/29/2003US6599739 Papillomavirus viral vector for use in the transfer of nucleotide sequences
07/29/2003US6599727 Human poly (ADP-ribose) polymerase 2 materials and methods
07/29/2003US6599537 Antiradical, cytophotoprotective, tyrosinase and melanogenesis inhibiting and antiprotease effects
07/29/2003US6599512 Electrolyte content w/o emulsions for treating irritated/sensitive skins
07/29/2003US6599499 Uses of diterpenoid triepoxides as an anti-proliferative agent
07/29/2003CA2210444C Keratinocyte growth factor-2
07/29/2003CA2185036C Use of a non photosynthetic filamentous bacteria extract and composition containing the same
07/29/2003CA2094280C A method for transplanting cells into the brain and therapeutic uses therefor
07/29/2003CA2078379C Method of treating immunoinflammatory disease
07/29/2003CA2056065C Preparation of 3-alkylated indoles
07/29/2003CA2048959C 3-(1,2-benzisoxazol-3-yl)-4-pyridinamines and derivatives
07/24/2003WO2003060521A2 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation
07/24/2003WO2003060149A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
07/24/2003WO2003060090A2 Novel cytokine zcytor17 ligand
07/24/2003WO2003060085A2 Mammalian neural stem cells, compositions and uses thereof
07/24/2003WO2003060082A2 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
07/24/2003WO2003060034A1 Anion generating material and skin treating agent using the same
07/24/2003WO2003059951A2 Novel anti-igf-ir antibodies and uses thereof
07/24/2003WO2003059950A1 Ifnar2 mutants, their production and use